Abstract
The field of inhaled antibiotics that target Pseudomonas aeruginosa infections has made substantial contributions to the health, disease management, and life expectancies of individuals with cystic fibrosis (CF) over the last three decades [1-3]. This paper reviews some of the recent clinical developments in the field of inhaled antibiotics for CF and briefly describes formulations and ongoing developments for US and/or European regulatory approvals. Lung delivery technologies, in regards to inhaled antibiotics for CF, are also reviewed
Keywords: Inhaled antibiotics, Pseudomonas aeruginosa, cystic fibrosis, aerosol, lung delivery, pneumonia, aerosolized application, tobramycin, drug delivery, nebulizer
Current Pharmaceutical Design
Title: New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa
Volume: 18 Issue: 5
Author(s): Thomas Hofmann
Affiliation:
Keywords: Inhaled antibiotics, Pseudomonas aeruginosa, cystic fibrosis, aerosol, lung delivery, pneumonia, aerosolized application, tobramycin, drug delivery, nebulizer
Abstract: The field of inhaled antibiotics that target Pseudomonas aeruginosa infections has made substantial contributions to the health, disease management, and life expectancies of individuals with cystic fibrosis (CF) over the last three decades [1-3]. This paper reviews some of the recent clinical developments in the field of inhaled antibiotics for CF and briefly describes formulations and ongoing developments for US and/or European regulatory approvals. Lung delivery technologies, in regards to inhaled antibiotics for CF, are also reviewed
Export Options
About this article
Cite this article as:
Hofmann Thomas, New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa, Current Pharmaceutical Design 2012; 18 (5) . https://dx.doi.org/10.2174/138161212799315975
DOI https://dx.doi.org/10.2174/138161212799315975 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry Pharmacogenomics in Drug Induced Liver Injury
Current Drug Metabolism Intracellular Signaling Pathways Modulated by Phenolic Compounds: Application for New Anti-Inflammatory Drugs Discovery
Current Medicinal Chemistry Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) The Putative Adverse Effects of Bisphenol A on Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease
Current Pharmaceutical Design Promising Protective Effects of Chrysin in Cardiometabolic Diseases
Current Drug Targets Study on the Effect of HPMC on Compression Coated Floating Pulsatile Delivery of Bisoprolol
Current Drug Therapy Editorial [Hot topic: Childhood Asthma - The State of Play in 2010 (Guest Editor: Steve Turner)]
Current Pediatric Reviews Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry Tobacco Smoke Exposure, Nicotine, and the Embryologic Origins of Asthma
Current Respiratory Medicine Reviews Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Glucocorticoid Osteoporosis
Current Pharmaceutical Design Efficacy and Safety of H1-Antihistamines: An Update
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Relevance of Bioassay of Biologically Active Substances (BAS) with Geroprotective Properties in the Model of the Nematode <i>Caenorhabditis Elegans</i> in <i>In Vivo</i> Experiments
Current Aging Science Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase. 2. Investigation of the Carboxamide Portion of Spirocyclic Piperidine Amides
Letters in Drug Design & Discovery Role of Nitric Oxide in the Modulation of Angiogenesis
Current Pharmaceutical Design Macrolide Therapy Targets a Specific Phenotype in Respiratory Medicine: From Clinical Experience to Basic Science and Back
Inflammation & Allergy - Drug Targets (Discontinued) Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mitochondrial Mechanisms of Metabolic Reprogramming in Proliferating Cells
Current Medicinal Chemistry